摘要
目的:评价干扰素治疗丙型肝炎的疗效和安全性。方法:综合近几年有关中、外文献进行分析、评价。结果:干扰素单一用药或 联合用药治疗丙型肝炎均有效,但联合用药比单一用药疗效为优。结论:干扰素价格较贵,毒副作用较大,耐受性差,但仍是目前治 疗丙型肝炎最有效的抗病毒药物。因此,研制和开发治疗丙型肝炎的新药乃是当务之急。
OBJECTIVE:To evaluate the clinical efficacy and safety of interferon(IF) in treatment of hepatitis C.METHODS: The data in literature, published in recent years, were analysed and evaluated.RESULTS: IF or IF in combination with other drugs was effective in treating hepatitis C, however, IF in combination with other drugs showed better therapeutic efficacy .CONCLUSION: IF is expensive in price and severe in side effects, still it is the most effective antiviral agent in treating hepatitis C at present .Development of new drugs for hepatitis C is a pressing matter of the moment.
出处
《中国医院用药评价与分析》
2001年第4期215-216,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
